Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 33: 273-277, 1987;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huebers, H. A.
Right arrow Articles by Finch, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huebers, H. A.
Right arrow Articles by Finch, C. A.

Clinical Chemistry, Vol 33, 273-277, Copyright © 1987 by American Association for Clinical Chemistry

Plasma iron and transferrin iron-binding capacity evaluated by colorimetric and immunoprecipitation methods

HA Huebers, MJ Eng, BM Josephson, N Ekpoom, RL Rettmer, RF Labbe, P Pootrakul and CA Finch

We evaluated plasma iron (PI) and total iron-binding capacity (TIBC) or transferrin in normal individuals and in patients with iron imbalance. The standard colorimetric measurements of PI and TIBC and the standard isotope-dilution measurement of TIBC were compared with an immunoprecipitation method and also with immunoelectrophoresis of transferrin. PI concentrations as measured by the standard and immunoprecipitation methods agreed closely for all individuals except those with saturated transferrin, where nontransferrin iron increased the results in the standard assay. This excess iron in saturated plasma may be derived from either free iron or iron-bearing ferritin. There were also differences in TIBC between the two methods. Iron-deficient sera gave higher values for transferrin when measured by immunoelectrophoresis. Unsaturated iron-binding capacity was increased in the isotope-dilution method in some iron-saturated plasma, compounding errors when added to erroneously high PI values to compute TIBC. Perhaps some exchange of iron occurred between added iron and transferrin iron in the isotope-dilution method. These measurements confirm the accuracy of the standard colorimetric method of measuring PI and TIBC except in iron-saturated plasma. However, the greater specificity of a polyclonal immunoprecipitation method of measuring PI and TIBC makes it particularly useful in differentiating transferrin- bound iron from nontransferrin iron.


The following articles in journals at HighWire Press have cited this article:


Home page
 BloodHome page
Y.-S. Sohn, W. Breuer, A. Munnich, and Z. I. Cabantchik
Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications
Blood, February 1, 2008; 111(3): 1690 - 1699.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
C. Chaudhury, J. Kim, S. Mehnaz, M. A. Wani, T. M. Oberyszyn, C. L. Bronson, S. Mohanty, W. L. Hayton, J. M. Robinson, and C. L. Anderson
Accelerated Transferrin Degradation in HFE-Deficient Mice Is Associated with Increased Transferrin Saturation
J. Nutr., December 1, 2006; 136(12): 2993 - 2998.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
H. Yamanishi, S. Iyama, Y. Yamaguchi, Y. Kanakura, and Y. Iwatani
Total Iron-binding Capacity Calculated from Serum Transferrin Concentration or Serum Iron Concentration and Unsaturated Iron-binding Capacity
Clin. Chem., January 1, 2003; 49(1): 175 - 178.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
H. Yamanishi, S. Iyama, Y. Yamaguchi, Y. Kanakura, and Y. Iwatani
Modification of Fully Automated Total Iron-binding Capacity (TIBC) Assay in Serum and Comparison with Dimension TIBC Method
Clin. Chem., September 1, 2002; 48(9): 1565 - 1570.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. E. Purkey, M. I. Dorrell, and J. W. Kelly
Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma
PNAS, May 8, 2001; 98(10): 5566 - 5571.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. Gambino, E. Desvarieux, M. Orth, H. Matan, T. Ackattupathil, E. Lijoi, C. Wimmer, J. Bower, and E. Gunter
The relation between chemically measured total iron-binding capacity concentrations and immunologically measured transferrin concentrations in human serum
Clin. Chem., December 1, 1997; 43(12): 2408 - 2412.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
H. Yamanishi, S. Kimura, S. Iyama, Y. Yamaguchi, and T. Yanagihara
Fully automated measurement of total iron-binding capacity in serum
Clin. Chem., December 1, 1997; 43(12): 2413 - 2417.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by the American Association for Clinical Chemistry.